You are here
Over the years Lero research has been responsible for the creation of a number of successful spin-out companies, such as Nova Leah, and LogEntries.
Nova Leah, a Lero and Dundalk Institute of Technology start-up, is leading the field globally in the development of technology to prevent defibrillator, pacemakers and other connected medical devices from being maliciously hacked. Launched in 2016, by 2020 the company employed more than 50 people creating an intelligent cyber-security risk-assessment management tool for medical devices. The company is currently providing its SelectEvidence application to large US medical device companies.
Nova Leah is an Enterprise Ireland High Potential Start Up and received €2.25 million VC funding. In 2017, Nova Leah won several national awards including Start-Up Company of the Year and Emerging Technology Start-Up Company of the Year. Nova Leah was also successful in winning two Disruptive Technologies Innovation Fund (DTIF) funding awards, one as a lead partner and the other as a consortium member. The company won Best Overall Start-Up in Ireland in 2018. Nova Leah founder Dr Anita Finnegan and Professor Fergal McCaffery won the Science Foundation Ireland Award for Entrepreneurship in 2020.
In December 2021, Nova Leah announced that Northwell Holdings, the venture investment arm of Northwell Health, led an investment in the Louth-based company. The investment was timed to support Nova Leah in expanding its technology footprint across the US, bringing its real-time threat monitoring product portfolio into health care delivery systems.
Based on Lero UCD research with IBM, LogEntries, is a company that that was co-founded in 2010 by Dr Trevor Parsons and Dr Viliam Holub as a spin-out from UCD’s Performance Engineering Laboratory in the UCD School of Computer Science. The company currently employs 70 people and develops platforms that analyse systems logs. The company was acquired by Rapid7 for $68m dollars in 2016.